Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

13.2%

5 terminated out of 38 trials

Success Rate

80.8%

-5.7% vs benchmark

Late-Stage Pipeline

21%

8 trials in Phase 3/4

Results Transparency

48%

10 of 21 completed with results

Key Signals

10 with results81% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (6)
P 1 (9)
P 2 (9)
P 3 (3)
P 4 (5)

Trial Status

Completed21
Unknown6
Terminated5
Recruiting4
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

80.8%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT04975334Phase 1CompletedPrimary

Opioid Antagonism in Hypogonadotropic Hypogonadism

NCT05971836Active Not RecruitingPrimary

The Molecular Basis of Inherited Reproductive Disorders

NCT04648969Phase 2CompletedPrimary

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

NCT07224438Phase 2Recruiting

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

NCT05633966Phase 1Completed

Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

NCT05896293Phase 2RecruitingPrimary

Kisspeptin Administration Subcutaneously to Patients With IHH

NCT04456296Phase 4Completed

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

NCT06357442Recruiting

Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.

NCT00914823Phase 1CompletedPrimary

Kisspeptin Administration in the Adult

NCT01952782Phase 1CompletedPrimary

Neuropeptides in Human Reproduction

NCT01709331Phase 3Completed

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

NCT03019575Phase 3CompletedPrimary

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)

NCT05752591Completed

Hypothalamic-pituitary Dysfunction in Diabetes

NCT05205837Phase 4Terminated

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

NCT01438034Phase 1Completed

Kisspeptin in the Evaluation of Delayed Puberty

NCT04252001Not ApplicableNot Yet Recruiting

Growing up With the Young Endocrine Support System (YESS!)

NCT02908074Phase 2CompletedPrimary

A 6 Month Safety Extension Study of MBGS205

NCT05808647Not ApplicableUnknownPrimary

Low Energy Availability and Pituitary Function (LEAP Study)

NCT02730169Phase 2CompletedPrimary

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

NCT00392756Phase 1Completed

Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

Scroll to load more

Research Network

Activity Timeline